217 related articles for article (PubMed ID: 34511602)
1. EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties.
Zhou K; Sun Y; Dong D; Zhao C; Wang W
Cell Death Dis; 2021 Sep; 12(9):844. PubMed ID: 34511602
[TBL] [Abstract][Full Text] [Related]
2. Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma.
Hong XC; Fen YJ; Yan GC; Hong H; Yan CH; Bing LW; Zhong YH
Mol Med Rep; 2015 Nov; 12(5):6445-50. PubMed ID: 26398721
[TBL] [Abstract][Full Text] [Related]
3. E2F3 induces DNA damage repair, stem-like properties and therapy resistance in breast cancer.
Wei L; Bai Y; Na L; Sun Y; Zhao C; Wang W
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166816. PubMed ID: 37499929
[TBL] [Abstract][Full Text] [Related]
4. EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations.
Zhou W; Jiang Z; Li X; Xu F; Liu Y; Wen P; Kong L; Hou M; Yu J
J Korean Med Sci; 2009 Feb; 24(1):97-103. PubMed ID: 19270820
[TBL] [Abstract][Full Text] [Related]
5. Epithelial membrane protein 3 regulates lung cancer stem cells via the TGF‑β signaling pathway.
Kahm YJ; Kim RK; Jung U; Kim IG
Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476496
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
7. YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance.
Sun Y; Dong D; Xia Y; Hao L; Wang W; Zhao C
Cell Death Dis; 2022 Mar; 13(3):230. PubMed ID: 35279688
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM.
Kim SY; Rhee JG; Song X; Prochownik EV; Spitz DR; Lee YJ
PLoS One; 2012; 7(11):e50423. PubMed ID: 23185620
[TBL] [Abstract][Full Text] [Related]
9. Senescence evasion by MCF-7 human breast tumor-initiating cells.
Karimi-Busheri F; Rasouli-Nia A; Mackey JR; Weinfeld M
Breast Cancer Res; 2010; 12(3):R31. PubMed ID: 20525204
[TBL] [Abstract][Full Text] [Related]
10. Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Xue Q; Zhou Y; Wan C; Lv L; Chen B; Cao X; Ju G; Huang Y; Ni R; Mao G
Exp Mol Pathol; 2013 Dec; 95(3):313-8. PubMed ID: 23920144
[TBL] [Abstract][Full Text] [Related]
11. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
Cha YJ; Koo JS
PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks.
Shirode AB; Kovvuru P; Chittur SV; Henning SM; Heber D; Reliene R
Mol Carcinog; 2014 Jun; 53(6):458-70. PubMed ID: 23359482
[TBL] [Abstract][Full Text] [Related]
13. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway.
Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C
Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386
[TBL] [Abstract][Full Text] [Related]
14. CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion.
Jiao X; Velasco-Velázquez MA; Wang M; Li Z; Rui H; Peck AR; Korkola JE; Chen X; Xu S; DuHadaway JB; Guerrero-Rodriguez S; Addya S; Sicoli D; Mu Z; Zhang G; Stucky A; Zhang X; Cristofanilli M; Fatatis A; Gray JW; Zhong JF; Prendergast GC; Pestell RG
Cancer Res; 2018 Apr; 78(7):1657-1671. PubMed ID: 29358169
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
16. METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.
Zhang C; Chen L; Peng D; Jiang A; He Y; Zeng Y; Xie C; Zhou H; Luo X; Liu H; Chen L; Ren J; Wang W; Zhao Y
Mol Cell; 2020 Aug; 79(3):425-442.e7. PubMed ID: 32615088
[TBL] [Abstract][Full Text] [Related]
17. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation.
Christians A; Poisel E; Hartmann C; von Deimling A; Pusch S
Int J Cancer; 2019 Jul; 145(2):461-473. PubMed ID: 30614533
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.
Somyajit K; Subramanya S; Nagaraju G
J Biol Chem; 2012 Jan; 287(5):3366-80. PubMed ID: 22167183
[TBL] [Abstract][Full Text] [Related]
20. RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.
Martin RW; Orelli BJ; Yamazoe M; Minn AJ; Takeda S; Bishop DK
Cancer Res; 2007 Oct; 67(20):9658-65. PubMed ID: 17942895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
